The food and drug administration (FDA ) approves Moderna's coronavirus vaccine for emergency use . After Pfizer and BioNtech's vaccine it is the second vaccine which was approved in USA .
The FDA’s emergency use authorization approves the federal
government’s plan to distribute roughly 5.9 million doses of Moderna’s
vaccine to 64 states, territories and major cities across the nation
next week.
The potentially lifesaving shots are desperately needed to fend off the pandemic that has taken more than 300,000 American lives and overwhelmed hospitals.
U.S. officials hope to vaccinate at least 20 million Americans — mostly front-line health-care workers and nursing home residents — by the end of the year. Initial doses will be limited as manufacturing ramps up, with officials predicting it will take months to immunize everyone in the U.S. who wants to be vaccinated
The FDA authorized Moderna’s vaccine for people who are 18 years old and
older. Such an authorization from the agency isn’t the same as full
approval, which requires more data and can typically take several months
longer. Moderna has submitted only two months of follow-up safety data.
The agency usually requires six months for full approval and can always
revoke an EUA for a drug if it doesn’t work as intended or proves to be
unsafe. The FDA approved the emergency use of hydroxychloroquine to
treat Covid-19 in March, only to revoke it in June after additional data
showed it provided “no evidence of benefit” in coronavirus patients .
No comments:
Post a Comment